Ligand recognition by the vitamin D receptor

Mihwa Choi, Keiko Yamamoto, Hiroyuki Masuno, Kinichi Nakashima, Tetsuya Taga, Sachiko Yamada

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Three dimensional structure of the ligand binding domain (LBD) of the vitamin D receptor (VDR) docked with the natural ligand 1α,25-dihydroxyvitamin D3 [1,25-(OH)2D3] has been mostly solved by the X-ray crystallographic analysis of the deletion mutant (VDR-LBDΔ165-215). The important focus, from now on is how the VDR recognizes and interacts with potent synthetic ligands. We now report the docking models of the VDR with three functionally and structurally interesting ligands, 22-oxa-1,25-(OH)2D3 (OCT), 20-epi-1,25-(OH)2D3 and 20-epi-22-oxa-24,26,27-trihomo-1,25-(OH)2D3. In parallel with the computational docking studies, we prepared twelve one-point mutants of amino acid residues lining the ligand binding pocket of the VDR and examined their transactivation potency induced by 1,25-OH)2D3 and these synthetic ligands. The results indicate that L233, R274, W286, H397 and Y401 are essential for holding the all ligands tested, S278 and Q400 are not important at all, and the importance of S237, V234, S275, C288 and H305 is variable depending on the side-chain structure of the ligands. Based on these studies, we suggested key structural factors to bestow the selective action on OCT and the augmented activities on 20-epi-ligands. Furthermore, the docking models coincided well with our proposed active space-region theory of vitamin D based on the conformational analyses of ligands.

Original languageEnglish
Pages (from-to)1721-1730
Number of pages10
JournalBioorganic and Medicinal Chemistry
Volume9
Issue number7
DOIs
Publication statusPublished - Jul 26 2001
Externally publishedYes

Fingerprint

Calcitriol Receptors
Ligands
Calcitriol
Linings
Vitamin D
Transcriptional Activation
X-Rays
Amino Acids
X rays

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Ligand recognition by the vitamin D receptor. / Choi, Mihwa; Yamamoto, Keiko; Masuno, Hiroyuki; Nakashima, Kinichi; Taga, Tetsuya; Yamada, Sachiko.

In: Bioorganic and Medicinal Chemistry, Vol. 9, No. 7, 26.07.2001, p. 1721-1730.

Research output: Contribution to journalArticle

Choi, M, Yamamoto, K, Masuno, H, Nakashima, K, Taga, T & Yamada, S 2001, 'Ligand recognition by the vitamin D receptor', Bioorganic and Medicinal Chemistry, vol. 9, no. 7, pp. 1721-1730. https://doi.org/10.1016/S0968-0896(01)00060-8
Choi, Mihwa ; Yamamoto, Keiko ; Masuno, Hiroyuki ; Nakashima, Kinichi ; Taga, Tetsuya ; Yamada, Sachiko. / Ligand recognition by the vitamin D receptor. In: Bioorganic and Medicinal Chemistry. 2001 ; Vol. 9, No. 7. pp. 1721-1730.
@article{c0aea88b3e434aa0bd95247fa867f509,
title = "Ligand recognition by the vitamin D receptor",
abstract = "Three dimensional structure of the ligand binding domain (LBD) of the vitamin D receptor (VDR) docked with the natural ligand 1α,25-dihydroxyvitamin D3 [1,25-(OH)2D3] has been mostly solved by the X-ray crystallographic analysis of the deletion mutant (VDR-LBDΔ165-215). The important focus, from now on is how the VDR recognizes and interacts with potent synthetic ligands. We now report the docking models of the VDR with three functionally and structurally interesting ligands, 22-oxa-1,25-(OH)2D3 (OCT), 20-epi-1,25-(OH)2D3 and 20-epi-22-oxa-24,26,27-trihomo-1,25-(OH)2D3. In parallel with the computational docking studies, we prepared twelve one-point mutants of amino acid residues lining the ligand binding pocket of the VDR and examined their transactivation potency induced by 1,25-OH)2D3 and these synthetic ligands. The results indicate that L233, R274, W286, H397 and Y401 are essential for holding the all ligands tested, S278 and Q400 are not important at all, and the importance of S237, V234, S275, C288 and H305 is variable depending on the side-chain structure of the ligands. Based on these studies, we suggested key structural factors to bestow the selective action on OCT and the augmented activities on 20-epi-ligands. Furthermore, the docking models coincided well with our proposed active space-region theory of vitamin D based on the conformational analyses of ligands.",
author = "Mihwa Choi and Keiko Yamamoto and Hiroyuki Masuno and Kinichi Nakashima and Tetsuya Taga and Sachiko Yamada",
year = "2001",
month = "7",
day = "26",
doi = "10.1016/S0968-0896(01)00060-8",
language = "English",
volume = "9",
pages = "1721--1730",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "7",

}

TY - JOUR

T1 - Ligand recognition by the vitamin D receptor

AU - Choi, Mihwa

AU - Yamamoto, Keiko

AU - Masuno, Hiroyuki

AU - Nakashima, Kinichi

AU - Taga, Tetsuya

AU - Yamada, Sachiko

PY - 2001/7/26

Y1 - 2001/7/26

N2 - Three dimensional structure of the ligand binding domain (LBD) of the vitamin D receptor (VDR) docked with the natural ligand 1α,25-dihydroxyvitamin D3 [1,25-(OH)2D3] has been mostly solved by the X-ray crystallographic analysis of the deletion mutant (VDR-LBDΔ165-215). The important focus, from now on is how the VDR recognizes and interacts with potent synthetic ligands. We now report the docking models of the VDR with three functionally and structurally interesting ligands, 22-oxa-1,25-(OH)2D3 (OCT), 20-epi-1,25-(OH)2D3 and 20-epi-22-oxa-24,26,27-trihomo-1,25-(OH)2D3. In parallel with the computational docking studies, we prepared twelve one-point mutants of amino acid residues lining the ligand binding pocket of the VDR and examined their transactivation potency induced by 1,25-OH)2D3 and these synthetic ligands. The results indicate that L233, R274, W286, H397 and Y401 are essential for holding the all ligands tested, S278 and Q400 are not important at all, and the importance of S237, V234, S275, C288 and H305 is variable depending on the side-chain structure of the ligands. Based on these studies, we suggested key structural factors to bestow the selective action on OCT and the augmented activities on 20-epi-ligands. Furthermore, the docking models coincided well with our proposed active space-region theory of vitamin D based on the conformational analyses of ligands.

AB - Three dimensional structure of the ligand binding domain (LBD) of the vitamin D receptor (VDR) docked with the natural ligand 1α,25-dihydroxyvitamin D3 [1,25-(OH)2D3] has been mostly solved by the X-ray crystallographic analysis of the deletion mutant (VDR-LBDΔ165-215). The important focus, from now on is how the VDR recognizes and interacts with potent synthetic ligands. We now report the docking models of the VDR with three functionally and structurally interesting ligands, 22-oxa-1,25-(OH)2D3 (OCT), 20-epi-1,25-(OH)2D3 and 20-epi-22-oxa-24,26,27-trihomo-1,25-(OH)2D3. In parallel with the computational docking studies, we prepared twelve one-point mutants of amino acid residues lining the ligand binding pocket of the VDR and examined their transactivation potency induced by 1,25-OH)2D3 and these synthetic ligands. The results indicate that L233, R274, W286, H397 and Y401 are essential for holding the all ligands tested, S278 and Q400 are not important at all, and the importance of S237, V234, S275, C288 and H305 is variable depending on the side-chain structure of the ligands. Based on these studies, we suggested key structural factors to bestow the selective action on OCT and the augmented activities on 20-epi-ligands. Furthermore, the docking models coincided well with our proposed active space-region theory of vitamin D based on the conformational analyses of ligands.

UR - http://www.scopus.com/inward/record.url?scp=0034940773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034940773&partnerID=8YFLogxK

U2 - 10.1016/S0968-0896(01)00060-8

DO - 10.1016/S0968-0896(01)00060-8

M3 - Article

C2 - 11425573

AN - SCOPUS:0034940773

VL - 9

SP - 1721

EP - 1730

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 7

ER -